Search for a command to run...
Human papillomaviruses (HPV) comprise a taxonomically diverse family of non-enveloped double-stranded DNA viruses (Papillomaviridae) causally associated with cervical cancer, oropharyngeal carcinoma, and a spectrum of anogenital and cutaneous malignancies. Despite the existence of efficacious prophylactic vaccines and validated molecular diagnostic platforms, scientific communication of HPV taxonomy, oncogenic risk stratification, and diagnostic performance remains fragmented across disparate literature sources, institutional databases, and commercial product documentation. The KPAI HPV Reference Hub v3.0 is a fully self-contained, open-access interactive hub developed in R (R Markdown/htmltools) that consolidates authoritative HPV reference data into a single, navigable scientific resource for researchers, clinical virologists, molecular epidemiologists, public health scientists, and postgraduate students. The hub integrates data from the International Committee on Taxonomy of Viruses (ICTV), the HPV Reference Center at Karolinska Institutet, the Papillomavirus Episteme (PaVE) database, and the International Agency for Research on Cancer (IARC), covering: (1) complete ICTV-compliant Papillomaviridae taxonomy across 5 human genera, 49 species, and 231 reference genotypes with GenBank accession numbers; (2) formally characterised intratype lineages and sub-lineages for clinically significant types including HPV16, 18, 31, 33, 45, 52, and 58, with geographic distributions and oncogenic risk differentials; (3) IARC Group 1, 2A, and 2B oncogenic risk classifications for all assessed genotypes; (4) annotated HPV genome organisation and gene-level oncogenic mechanisms; (5) a critical evaluation of 264+ commercial HPV molecular diagnostic assays benchmarked against IARC 100B validation criteria, with documented discordances between manufacturer instructions for use and IARC risk classifications for Group 2B types (HPV67, HPV70, HPV73, HPV82); (6) HPV co-infection interactome network analysis based on observed/expected co-detection ratios from published epidemiological data; and (7) vaccine genotype coverage profiles for licensed prophylactic vaccines. A central scientific contribution of this resource is its systematic documentation of risk misclassification in commercially available HPV assay platforms, wherein IARC Group 2B types are labelled as low-risk in manufacturer documentation, a practice with direct implications for cervical cancer screening programme design and outcome interpretation. All data are presented with primary literature citations, and the dashboard is structured to function as a living, versioned reference resource for the global HPV research community.